Prescription digital medicine company Akili inks $55 mln Series C

Boston and San Francisco Bay Area-based Akili Interactive, a prescription digital medicine company, has secured $55 million in Series C financing. Temasek led the round with participation from other investors that included Baillie Gifford, Amgen Ventures, M Ventures, JAZZ Venture Partners, Canepa Advanced Healthcare Fund and Brooklands Capital Strategies.

Source: Press Release